Diabetes Education News

The FDA issued a warning for consumers to avoid using a nonprescription product currently being sold for blood glucose management due to risks for adverse events, according to an agency press release.

Women living in low- and middle-income countries have a higher prevalence of obesity and other cardiometabolic disorders than men, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

DENVER — People living with diabetes have the same nutrient needs as all well-nourished people, yet food is often a main source of stress or even disordered eating, according to a speaker at the Lifestyle Medicine Conference.

BOSTON — Patients struggling to meet cardiometabolic treatment targets may benefit from an assessment of social determinants of health, which could reveal food, housing or financial insecurity issues that play a large role in their health.

Children with new-onset type 1 diabetes had better preservation of beta-cell function with two 12-day courses of teplizumab compared with those receiving placebo, according to findings published in The New England Journal of Medicine.

BOSTON — Interventions that prevent or delay the onset of type 2 diabetes are critically important, and early diagnosis and treatment intensification can improve outcomes and increase lifespan, according to a speaker.

BOSTON — In this Healio video exclusive, Anne L. Peters, MD, delineates how the diagnosis of diabetes is heterogeneous and requires clinicians to “individualize our assessment of patients, and therefore our treatment of patients.”

BOSTON — Simple steps to optimize poor sleep habits can translate to large gains in cardiometabolic health, including improvements in BP, insulin resistance and even appetite regulation, according to a speaker.

DALLAS — Oral semaglutide improves HbA1c and may prevent progression to type 2 diabetes for adults with prediabetes, according to a speaker at ObesityWeek.

BOSTON — Continuous glucose monitoring is becoming a mainstay of care for people with type 1 and type 2 diabetes, yet providers should be cautious about the technology’s application for people without diabetes looking for a “wellness” tool.